FDA said ok to Allergen’s breast implants
January 4, 2017Allergan has won FDA’s approval to sell its breast implants in US.
Allergan has received approval to market Natrelle inspira SoftTouch breast implants, offering women undergoing breast reconstruction, augmentation or revision surgery a new medium firmness gel, or cohesive, implant option. With this addition the Natrelle line of breast implants is the only implant line with three levels of cohesive gel, said the company in its press release issued on Tuesday.
“Adding Natrelle inspira SoftTouch breast implants to our already robust line of offerings gives Allergan the most extensive variety of implants in the industry and provides doctors with a wide range of options,” said David Nicholson, Chief R&D Officer of Allergan plc.
